Explore the latest pharmaceutical additions and clinical edits in the MO HealthNet Pharmacy Program for various conditions like Fabry disease, cystic fibrosis, generalized myasthenia gravis, and more. Discover new medications such as Elfabrio, Kalydeco, Rystiggo, and Trikafta along with their indica

1 views • 19 slides

Myasthenia gravis is a condition characterized by muscle weakness and rapid fatigue due to communication issues between nerves and muscles. While there is no cure, treatment options are available to manage symptoms such as weakness, double vision, and difficulties with speech and swallowing. Factors

0 views • 21 slides

Overview of pharmacological treatment options for Parkinson's disease and related conditions like choreatic dyskinesias, spastic disorders, and myasthenia gravis. Describes the degenerative process of Parkinson's disease, its symptoms, and the pharmacological interventions targeting dopamine deficit

0 views • 26 slides

Myasthenia Gravis (MG) is a neuromuscular disorder characterized by muscle weakness and fatigability due to a decrease in acetylcholine receptors at neuromuscular junctions. It primarily affects individuals in two age peaks, with different symptoms and gender predominance. The cardinal feature is we

0 views • 25 slides